Knockdown of Dbr1 activity was recently demonstrated to suppress the toxic effects of the nucleic acid-binding protein TDP-43 in cell models of amyotropic lateral sclerosis (ALS) (18). Here, TARDBP is linked to amyotrophic lateral sclerosis.